Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.52 | 36.77 |
PEG Ratio (TTM) | -0.29 | 1.44 |
P/S Ratio (TTM) | 0.24 | 3.72 |
P/B Ratio (TTM) | 4.65 | 25.91 |
P/FCF Ratio (TTM) | -3.56 | 24.94 |
Price to 5YR AVG Earnings Ratio | N/A | 28.09 |
Price to 5YR AVG FCF Ratio | N/A | 26.65 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -24.85% | 8.82% |
ROE (TTM) | -186.03% | 113.92% |
Net Profit Margin (TTM) | -14.41% | 11.28% |
ROIC 5YR AVG | N/A | 27.62% |
Growth (20%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -26.27% | 48.21% | N/A |
Revenue | -5.73% | 15.13% | N/A |
Net Income | -29.85% | 0.88% | N/A |
Cash Flow | -343.72% | 1.77% | N/A |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.88 | 1.00 |
Quick Ratio (TTM) | 2.92 | 0.73 |
D/E Ratio (TTM) | 7.01 | 3.22 |
Interest Coverage (TTM) | -1.03 | 26.29 |
Piotroski F-Score | 4 | 8 |
Altman Z-Score | N/A | 5.48 |
LTL to 5YR AVG FCF | N/A | 2.48 |
Shares Outstanding Growth 5YR AVG | N/A | -0.94% |